Marcello Rotta

1.7k total citations
29 papers, 756 citations indexed

About

Marcello Rotta is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Marcello Rotta has authored 29 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 9 papers in Public Health, Environmental and Occupational Health and 8 papers in Oncology. Recurrent topics in Marcello Rotta's work include Hematopoietic Stem Cell Transplantation (14 papers), Acute Myeloid Leukemia Research (12 papers) and Acute Lymphoblastic Leukemia research (9 papers). Marcello Rotta is often cited by papers focused on Hematopoietic Stem Cell Transplantation (14 papers), Acute Myeloid Leukemia Research (12 papers) and Acute Lymphoblastic Leukemia research (9 papers). Marcello Rotta collaborates with scholars based in United States, Italy and Germany. Marcello Rotta's co-authors include Benedetto Bruno, Rainer Storb, Mario Boccadoro, Luisa Giaccone, Massimo Massaia, Roberto Sorasio, Renato Fanin, Francesca Patriarca, Paola Omedè and Fabrizio Carnevale‐Schianca and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Marcello Rotta

27 papers receiving 742 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marcello Rotta United States	13	631	314	295	168	63	29	756
MV Mateos Spain	12	650 1.0×	261 0.8×	263 0.9×	158 0.9×	97 1.5×	37	750
Giuseppe Console Italy	15	475 0.8×	130 0.4×	302 1.0×	90 0.5×	87 1.4×	51	633
Jenna D. Goldberg United States	16	513 0.8×	178 0.6×	366 1.2×	131 0.8×	51 0.8×	27	638
MR Litzow United States	14	517 0.8×	237 0.8×	260 0.9×	113 0.7×	78 1.2×	14	631
Xiao‐Su Zhao China	17	632 1.0×	193 0.6×	143 0.5×	290 1.7×	86 1.4×	45	852
Sharon Tindle United States	9	639 1.0×	153 0.5×	312 1.1×	144 0.9×	102 1.6×	19	742
Chrissy Giles United Kingdom	10	368 0.6×	154 0.5×	194 0.7×	70 0.4×	54 0.9×	19	466
Liliane Dal Cortivo France	11	396 0.6×	107 0.3×	176 0.6×	326 1.9×	100 1.6×	19	670
Leandro de Pádua Silva United States	9	572 0.9×	226 0.7×	84 0.3×	120 0.7×	84 1.3×	25	746
Shannon R. McCurdy United States	17	602 1.0×	70 0.2×	219 0.7×	266 1.6×	71 1.1×	70	737

Countries citing papers authored by Marcello Rotta

Since Specialization

Citations

This map shows the geographic impact of Marcello Rotta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcello Rotta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcello Rotta more than expected).

Fields of papers citing papers by Marcello Rotta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcello Rotta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcello Rotta. The network helps show where Marcello Rotta may publish in the future.

Co-authorship network of co-authors of Marcello Rotta

This figure shows the co-authorship network connecting the top 25 collaborators of Marcello Rotta. A scholar is included among the top collaborators of Marcello Rotta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcello Rotta. Marcello Rotta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grieselhuber, Nicole R., Anjali S. Advani, Abdulraheem Yacoub, et al.. (2024). PF-08046040 (SEA-CD70), a Nonfucosylated CD70-Directed Antibody, in Combination with Azacitidine for Patients with Myelodysplastic Syndromes (MDS): A Phase 1 Dose-Finding and Dose Expansion Study. Blood. 144(Supplement 1). 1840–1840.

Battiwalla, Minoo, José C. Cruz, William B. Donnellan, et al.. (2024). Determinants of Outcomes for Acute Myeloid Leukemia Patients Treated in a Community-Based Specialized Versus Non-Specialized Hospital Setting. PubMed. 6(4). 43–52. 1 indexed citations

Rotta, Marcello, Yasmin Abaza, Hetty E. Carraway, et al.. (2024). Covalent-103: A phase 1, open-label, dose-escalation and expansion study of BMF-500, an oral covalent FLT3 inhibitor, in adults with acute leukemia (AL).. Journal of Clinical Oncology. 42(16_suppl). TPS6589–TPS6589. 3 indexed citations

Zeidan, Amer M., Eunice S. Wang, Ghayas C. Issa, et al.. (2024). Ziftomenib Combined with Intensive Induction (7+3) in Newly Diagnosed NPM1-m or KMT2A-r Acute Myeloid Leukemia: Interim Phase 1a Results from KOMET-007. Blood. 144(Supplement 1). 214–214. 14 indexed citations

Cutler, Corey, Stephanie J. Lee, Sally Arai, et al.. (2021). Belumosudil for Chronic Graft-Versus-Host Disease (cGVHD) after 2 or More Prior Lines of Therapy: The Rockstar Study (KD025-213). Transplantation and Cellular Therapy. 27(3). S7–S8. 3 indexed citations

Nash, Richard A., Ted Gooley, Tara Gregory, et al.. (2021). Non-Myeloablative Hematopoietic Stem Cell Transplantation (NMA HSCT) Utilizing Low-Dose Total Body Irradiation (TBI) Plus Fludarabine (Flu): A Comparison of Single-Center Based Flu 150 mg/m2 Plus 400 Cgy TBI Versus Flu 90 mg/m2 and 200 Cgy TBI Containing Regimens. Transplantation and Cellular Therapy. 27(3). S226–S227.

Bachier, Carlos, Gautam Borthakur, Chitra Hosing, et al.. (2020). A Phase 1 Study of NKX101, an Allogeneic CAR Natural Killer (NK) Cell Therapy, in Subjects with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-Risk Myelodysplastic Syndrome (MDS). Blood. 136(Supplement 1). 42–43. 25 indexed citations

Bachier, Carlos, et al.. (2020). Epidemiology and Treatment of Chronic Graft-versus-Host Disease Post-Allogeneic Hematopoietic Cell Transplantation: A US Claims Analysis. Transplantation and Cellular Therapy. 27(6). 504.e1–504.e6. 44 indexed citations

Ram, Ron, Barry E. Storer, Marco Mielcarek, et al.. (2011). Association between Calcineurin Inhibitor Blood Concentrations and Outcomes after Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 18(3). 414–422. 34 indexed citations

10.

Rotta, Marcello, Barry E. Storer, Rainer Storb, et al.. (2010). Impact of Recipient Statin Treatment on Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 16(10). 1463–1466. 36 indexed citations

11.

Ding, Yunchuan, Marcello Rotta, Scott S. Graves, et al.. (2009). Delaying DLA-Haploidentical Hematopoietic Cell Transplantation after Total Body Irradiation. Biology of Blood and Marrow Transplantation. 15(10). 1244–1250. 9 indexed citations

12.

Rotta, Marcello, Barry E. Storer, Rainer Storb, et al.. (2009). Donor statin treatment protects against severe acute graft-versus-host disease after related allogeneic hematopoietic cell transplantation. Blood. 115(6). 1288–1295. 42 indexed citations

13.

Rotta, Marcello, Barry E. Storer, Rainer Storb, et al.. (2009). Donor Statin Treatment Protects against Severe Acute Graft-Versus-Host Disease After Related Allogeneic Hematopoietic Cell Transplantation.. Blood. 114(22). 2227–2227. 2 indexed citations

14.

Rotta, Marcello, Barry E. Storer, Firoozeh Sahebi, et al.. (2008). Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting. Blood. 113(14). 3383–3391. 71 indexed citations

15.

Bruno, Benedetto, Marcello Rotta, Francesca Patriarca, et al.. (2007). A Comparison of Allografting with Autografting for Newly Diagnosed Myeloma. New England Journal of Medicine. 356(11). 1110–1120. 320 indexed citations

16.

Bruno, Benedetto, Roberto Sorasio, Francesca Patriarca, et al.. (2007). Unrelated donor haematopoietic cell transplantation after non‐myeloablative conditioning for patients with high‐risk multiple myeloma. European Journal Of Haematology. 78(4). 330–337. 17 indexed citations

17.

Bruno, Benedetto, Roberto Sorasio, Patrizia Barozzi, et al.. (2006). Kaposi's sarcoma triggered by endogenous HHV‐8 reactivation after non‐myeloablative allogeneic haematopoietic transplantation. European Journal Of Haematology. 76(4). 342–347. 20 indexed citations

18.

Sorasio, Roberto, Luisa Giaccone, Francesca Patriarca, et al.. (2006). Unrelated Donor Hematopoietic Cell Transplantation after Non-Myeloablative Conditioning for Patients with High Risk Multiple Myeloma.. Blood. 108(11). 3158–3158. 2 indexed citations

19.

Bruno, Benedetto, Francesca Patriarca, Roberto Sorasio, et al.. (2006). Bortezomib with or without dexamethasone in relapsed multiple myeloma following allogeneic hematopoietic cell transplantation.. PubMed. 91(6). 837–9. 31 indexed citations

20.

Bruno, Benedetto, Marcello Rotta, Luisa Giaccone, et al.. (2004). New drugs for treatment of multiple myeloma. The Lancet Oncology. 5(7). 430–442. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact